Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CRBP
Stock Latest News
Company Announcements
Corbus Aligns With FDA on CRB-701 Registrational Path
6d ago
8K
CRBP
Premium
The Fly
Corbus reports FDA alignment for CRB-701, CMO Dominic Smethurst departure
6d ago
CRBP
Premium
The Fly
Corbus Pharmaceuticals price target raised to $40 from $39 at Mizuho
7d ago
CRBP
Premium
Market News
3 Best Stocks to Buy Today, 4/3/2026, According to Top Analysts
10d ago
AVNW
CNTX
Premium
The Fly
Corbus Pharmaceuticals files $300M mixed securities shelf
1M ago
CRBP
Premium
The Fly
Corbus Pharmaceuticals price target raised to $57 from $53 at Oppenheimer
1M ago
CRBP
Premium
Ratings
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
1M ago
CRBP
Premium
Ratings
Corbus: Buy Rating Backed by CRB-701 Oncology Potential, Obesity Pipeline Catalysts, and Cash Runway Into 2028
1M ago
CRBP
Premium
Company Announcements
Corbus Pharmaceuticals Highlights 2025 Results and Pipeline Progress
1M ago
8K
CRBP
Premium
The Fly
Corbus Pharmaceuticals reports Q4 EPS ($1.25), consensus ($1.58)
1M ago
CRBP
Premium
Company Announcements
Corbus Highlights Diversified Oncology and Metabolic Pipeline Outlook
2M ago
8K
CRBP
Premium
Company Announcements
Corbus Advances Early-Stage Obesity Drug CRB-913: What Investors Should Watch Now
3M ago
CRBP
Premium
Company Announcements
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline
3M ago
8K
CRBP
Premium
Company Announcements
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer
4M ago
8K
CRBP
Premium
Ratings
Promising Initial Results and Strong Safety Profile Bolster Buy Rating for Corbus Pharmaceuticals’ CRB-913
4M ago
CRBP
Premium
Ratings
Optimistic Buy Rating for Corbus Pharmaceuticals: Promising Phase 1 Results for CRB-913 in Obesity Treatment
4M ago
CRBP
Premium
Ratings
Buy Rating for Corbus Pharmaceuticals Driven by Promising CRB-913 Developments and Market Potential
4M ago
CRBP
Premium
The Fly
RBC Capital says Corbus undervalued as ‘913 shows hints of weight loss
4M ago
CRBP
Premium
The Fly
Morning Movers: Oracle continues to slide despite earnings beat
4M ago
LLY
OXM
Premium
Company Announcements
Corbus Pharmaceuticals Advances Obesity Treatment with CRB-913
4M ago
8K
CRBP
Premium
The Fly
Corbus Pharmaceuticals reports results from Phase 1a study of CRB-913 in obesity
4M ago
CRBP
Premium
The Fly
Corbus Pharmaceuticals price target lowered to $53 from $55 at RBC Capital
5M ago
CRBP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
